Amycomycin, a process for its production and its use as a pharmaceutical

US6642391B2 · kind B2 · utility

Assignee

• Aventis Pharma Deutschland GmbH · DE

Inventors

• Cordula Hopmann · Berlin, DE
• Michael Kurz · Neustadt, DE
• Heinrich Decker · Eppstein, DE
• Dominique Le Beller · Compiègne, FR
• Jozsef Aszodi · Choisy-le-Roi, FR

Key dates

• Filing date: Dec 7, 2000
• Grant date: Nov 4, 2003
• Expiry date: Mar 29, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12P17/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A compound named Amycomycin of the formula: is described, as well as its pharmaceutically acceptable salts and derivatives, in all their stereoisomeric and tautomeric forms. The compound is obtained by growing the microorganism Amycolatopsis species ST101170 (DSM 12216) and is useful as a pharmaceutical, particularly as an antibiotic.